Skip to content
Dose Brief
Menu
No. 485 on the board · Grade C

Zealthy review

Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

Visit Zealthy Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $286/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
From $351/mo (starting dose, plus a separate fee, compounded)
Coverage
34 states
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $286/mo (starting dose, plus a separate fee, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Zealthy scored on our six Brief Score factors. See the methodology.

Price Stability34/100
Supply Reliability53/100
Transparency40/100
Access Breadth74/100
Clinical Oversight56/100
Track Record25/100

What we like

  • Serves 34 states — meaningful nationwide footprint
  • Asynchronous model removes friction for patients who don't want a video visit
  • Independent licensed prescribers retain full clinical authority

The caveats

  • Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
  • Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
  • Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
  • Recently rebranded to Gronk Inc. amid active enforcement
  • FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database

The brief

Best for: Readers who want not currently recommended — listed for transparency and reader awareness only. Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

Ranked #485 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest Zealthy — the realistic shortlist if you're weighing it.

Weighing Zealthy against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Zealthy, and every desk that outranks it is listed on the Zealthy alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Zealthy's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Zealthy's site. Not medical advice; see our disclosure.

← Back to all rankings